Chemotherapy and the Extra-Tumor Immune Microenvironment: EXTRA-TIME

Understandably, conventional therapeutic strategies have focused on controlling primary tumors. We ask whether the cost of such strategies is actually an increased likelihood of metastatic relapse.

Saved in:
Bibliographic Details
Published inCancer discovery Vol. 14; no. 4; pp. 643 - 647
Main Authors Phan, Tri Giang, Weilbaecher, Katherine N, Aft, Rebecca, Croucher, Peter I, Chaffer, Christine L
Format Journal Article
LanguageEnglish
Published United States 04.04.2024
Online AccessGet full text

Cover

More Information
Summary:Understandably, conventional therapeutic strategies have focused on controlling primary tumors. We ask whether the cost of such strategies is actually an increased likelihood of metastatic relapse.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2159-8274
2159-8290
DOI:10.1158/2159-8290.CD-23-1543